Posts about

Drug Discovery

Rebranding Repurposing: a Polypharmacological Perspective

“Drug repurposing doesn’t work. We’ve all tried it and it doesn’t work.” 

CONTINUE READING

How Cyclica's Innovation fuels our success and continuous drive to tackle low data targets

Over the years, many aspects of Cyclica’s business and technology have changed, sometimes...

CONTINUE READING

Drug Discovery on the Dark Proteome - Delivering Tomorrow's Medicines

The role of a given protein(s) to a specific disease or indication is a fundamental aspect of drug...

CONTINUE READING

The need for speed: how drug target discovery can drive change in precision medicine

Employee Perspective: Cyclica’s Marketing and Communications Specialist, Rebecca Woelfle

CONTINUE READING

Response to Scripps Research Institute Paper on DCAF-1

A vast majority of protein targets in the human proteome have been deemed undruggable given the...

CONTINUE READING

AI is not the Silver Bullet

As innovators, entrepreneurs, and operators, we have a responsibility to ensure that  our...

CONTINUE READING

Artificial Intelligence in Drug Discovery

Artificial Intelligence (AI) systems, specifically machine learning (ML) technologies, learn how to...

CONTINUE READING

AlphaFold 2: What No One Is Talking About

In this next installment of our AlphaFold Series, we look at the potential drawbacks and...

CONTINUE READING

Cyclica successfully integrates DeepMind’s AlphaFold 2

AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...

CONTINUE READING

Full Speed Ahead: What DeepMind’s Newest Revelation means for Scientific/Research Advancement

Last Week, DeepMind announced on their blog that they had made available, in collaboration with...

CONTINUE READING